Male Breast Cancer and Men of Color:
The Hidden Disparities behind an Overlooked Disease
An examination of
racial disparities, international patterns, social barriers and the urgent need
for more inclusive cancer detection.
PROLOGUE
Male breast cancer is an overlooked disease. For men of color, it
represents an even greater challenge, exposing disparities in healthcare,
cultural awareness, early detection, research participation and survival. While
breast cancer awareness has achieved remarkable progress, much of the public
conversation continues to exclude men, leaving important populations
inadequately represented in education, research and advocacy.
The
statistics reveal a troubling reality. Black men in the United States
experience disproportionately higher rates of male breast cancer than White
men, while international research identifies significant disease burdens in
parts of sub-Saharan Africa. Yet these numbers raise questions that extend
beyond genetics and biology. How many men remain undiagnosed? How many delay
seeking medical attention because breast cancer is perceived as a woman's
disease? How accurately do existing cancer registries represent underserved
populations?
This article
examines the available evidence, explores potential explanations for racial and
geographic disparities, and identifies opportunities to improve awareness,
screening, diagnostic access and research.
Most
importantly, it challenges us to reconsider how we communicate about male
breast cancer. Greater visibility, inclusive research and culturally responsive
education are essential to ensuring that every man, regardless of race,
ethnicity or nationality, has an opportunity for earlier detection and improved
survival.
THE
DISPARITIES WE CAN NO LONGER IGNORE
Male breast
cancer is already an underrecognized disease. For men of color, the challenges
can be compounded by racial disparities in cancer outcomes, unequal access to
healthcare, cultural misconceptions and a shortage of research addressing
different populations. Although breast cancer in men represents approximately
1% of all breast cancer diagnoses in the United States, its relatively low
incidence has contributed to a dangerous misconception: that all men face
essentially the same risks.
They do not.
Research has identified meaningful differences in incidence, age at diagnosis,
tumor characteristics and survival among racial and ethnic populations.
Understanding these differences requires examining not only biology but also
the social circumstances that determine who receives information, who seeks
medical attention and who obtains timely treatment.
The
American picture: What the numbers reveal
The American
Cancer Society estimates that approximately 2,670 American men will be
diagnosed with invasive breast cancer in 2026, while approximately 530 will die
from the disease. The average lifetime risk is approximately one in 755 men. However, these national estimates conceal
substantial disparities.
Source: American Cancer Society, Breast Cancer Facts & Figures 2024–2025.
A separate
American Cancer Society study found that Black men experienced 52% higher
breast cancer incidence than White men. Importantly, the disparity extended
across multiple tumor subtypes, suggesting that the problem cannot be
attributed to one particular form of breast cancer.
International
disparities: Where is the burden greatest?
The international
picture raises equally important questions. A Global Burden of Disease analysis
covering 204 countries and territories estimated 38,827 new male breast cancer
cases and 13,274 deaths worldwide in 2021.
International findings
Worldwide new
cases, 2021: 38,827
Worldwide deaths,
2021: 13,274
Eastern
sub-Saharan Africa: Highest estimated regional age-standardized incidence and
mortality rates.
Uganda: Highest estimated
national incidence and mortality rates in the analysis, at 4.54 and 3.51 per
100,000, respectively.
These are modeled
estimates, not complete national cancer registry counts.
These findings
warrant greater investigation into African populations and men of African
ancestry. However, geography should not be confused with ethnicity. African,
Caribbean, Hispanic, Asian, Indigenous and Middle Eastern populations are
internally diverse, and available evidence does not support assigning a uniform
breast cancer risk to any nationality.
Why
might these differences exist?
Researchers are
investigating several possible explanations, including inherited genetic
susceptibility, hormonal influences, obesity, environmental exposures and
differences in access to healthcare.
BRCA2 mutations
are an established male breast cancer risk factor, but the reasons for the
elevated incidence among Black men remain unresolved. Social and economic
inequalities may also contribute to differences in survival.
An important distinction
is necessary: genetic ancestry, nationality and socially defined race are not
interchangeable. Population-level disparities should generate research
questions rather than assumptions about individual patients.
The
social barriers: Why men remain invisible
Breast cancer
continues to be presented predominantly as a women's disease. For men,
particularly those in communities where masculinity, privacy and cultural
expectations discourage discussion of breast health, acknowledging symptoms may
present additional challenges.
These barriers
may be compounded by limited insurance coverage, mistrust of healthcare
institutions, inadequate culturally appropriate education and the absence of
male representation in breast cancer campaigns. Such explanations require
community-specific research rather than cultural generalizations.
The consequences
deserve attention. National Cancer Institute research indicates that Black men
are more likely than White men to receive a later-stage diagnosis and to die
from breast cancer.
Earlier
detection: A practical response
The solution is
not indiscriminate mammography for every man. It is informed, individualized
assessment and timely investigation of symptoms.
Healthcare
professionals and community advocates should prioritize five actions:
- Educate men
to recognize breast lumps, nipple discharge, nipple inversion, skin
changes and enlarged underarm lymph nodes.
- Encourage
prompt clinical assessment of suspicious changes, followed by diagnostic
mammography, ultrasound and biopsy when appropriate.
- Offer
genetic counseling and appropriate testing to men with breast cancer or
significant inherited risk.
- Discuss
individualized surveillance with men who have pathogenic BRCA variants or
other substantial risk factors.
- Expand
culturally appropriate outreach and improve racial, ethnic and ancestry
data collection in cancer registries.
Routine screening
mammography is not generally recommended for average-risk men. Screening
decisions for higher-risk men should be individualized.
Ultimately,
reducing disparities requires more than identifying which populations
experience greater risk. It demands research participation, culturally informed
education, accessible diagnostic services and public recognition that breast
cancer has no gender or racial boundaries.
Every man
deserves to recognize the warning signs, understand his individual risk and
receive timely care.
Research
references
1.
American
Cancer Society: Key Statistics for Breast Cancer in Men (2026)
2.
American
Cancer Society: Breast Cancer Facts & Figures 2024–2025
3.
Subtype-Specific
Breast Cancer Incidence Rates in Black Versus White Men
4.
Racial
and Ethnic Disparities and Socioeconomic Determinants of Male Breast Cancer
Mortality
5.
Global,
Regional and National Burden of Male Breast Cancer in 204 Countries
6.
National
Cancer Institute: Breast Cancer in Men
7.
National
Cancer Institute: Male Breast Cancer Treatment
8.
National
Cancer Institute: BRCA1 and BRCA2, Genetic Risk and Surveillance
References
The following references cover male breast cancer incidence, racial and
ethnic disparities, international epidemiology, genetics, screening, treatment
outcomes and barriers to care.
1. American Cancer Society. (2024). Breast cancer facts & figures
2024–2025. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2024/breast-cancer-facts-and-figures-2024.pdf
2. American Cancer Society. (2026). Key statistics for breast cancer in men.
https://www.cancer.org/cancer/types/breast-cancer-in-men/about/key-statistics.html
3. American College of Radiology. (2025). ACR Appropriateness Criteria®:
Male breast cancer screening. https://acsearch.acr.org/docs/3196044/Narrative
4. Crew, K. D., Neugut, A. I., Wang, X., Jacobson, J. S., Grann, V. R.,
Raptis, G., & Hershman, D. L. (2007). Racial disparities in treatment and
survival of male breast cancer. Journal of Clinical Oncology, 25(9), 1089–1098.
https://doi.org/10.1200/JCO.2006.09.1710
5. Freeman, J. Q., Schechter, K., Nguyen, L. C., Omoleye, O. J., & Hara,
J. H. (2026). Racial and ethnic disparities and socioeconomic determinants of
male breast cancer mortality in the United States. Breast Cancer Research and
Treatment, 215, Article 9. https://doi.org/10.1007/s10549-025-07851-y
6. Li, Y., Huang, Y., Huang, H., Wei, T., Zhang, A., Xing, L., Yin, X., Li,
H., Ren, G., & Li, F. (2025). Global, regional, and national burden of male
breast cancer in 204 countries and territories: A systematic analysis from the
Global Burden of Disease Study, 1990–2021. eClinicalMedicine, 80, Article
103027. https://doi.org/10.1016/j.eclinm.2024.103027
7. National Cancer Institute. (n.d.). BRCA gene changes: Cancer risk and
genetic testing fact sheet. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
8. National Cancer Institute. (n.d.). Male breast cancer treatment
(PDQ®)–Health professional version. https://www.cancer.gov/types/breast/hp/male-breast-treatment-pdq
9. National Cancer Institute. (n.d.). Male breast cancer treatment
(PDQ®)–Patient version. https://www.cancer.gov/types/breast/patient/male-breast-treatment-pdq
10. National Cancer Institute. (n.d.). Genetics of breast and gynecologic
cancers (PDQ®)–Health professional version. https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq
11. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022).
Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708
12. Sung, H., DeSantis, C., & Jemal, A. (2020). Subtype-specific breast
cancer incidence rates in Black versus White men in the United States. JNCI Cancer
Spectrum, 4(1), Article pkz091. https://doi.org/10.1093/jncics/pkz091
13. U.S. Cancer Statistics. (n.d.). U.S. cancer statistics data
visualizations. Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/uscs/dataviz/
14. World Health Organization. (2024). Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
15. World Health Organization, International Agency for Research on Cancer.
(2024). Global Cancer Observatory: Cancer today. https://gco.iarc.who.int/today/
No comments:
Post a Comment